Bristow Albert

Avg. Two Year Performance

No purchase track record
53% Avg. Sale Return
24% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(17%)8%7%48%53%
Sale Success Rate0 of 11 of 11 of 11 of 11 of 1

Barrier Therapeutics Inc.

Drugs » Biotechnology

General Counsel & Corp Sec'y, 10% Owner:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--